We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+9.06%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.6B
AUM Growth
+$2.6B
(+22%)
Cap. Flow
+$859M
Cap. Flow
% of AUM
5.88%
Top 10 Holdings %
Top 10 Hldgs %
21.92%
Holding
958
New
131
Increased
364
Reduced
334
Closed
74
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$135M |
| 2 |
Royal Bank of Canada
RY
|
+$120M |
| 3 |
Agilent Technologies
A
|
+$72.5M |
| 4 |
UnitedHealth
UNH
|
+$71.5M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$64.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$90.3M |
| 2 |
Amgen
AMGN
|
+$88.7M |
| 3 |
Allstate
ALL
|
+$52.2M |
| 4 |
Union Pacific
UNP
|
+$47.1M |
| 5 |
Bio-Rad Laboratories Class A
BIO
|
+$44.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.42% |
| 2 | Technology | 23.2% |
| 3 | Consumer Discretionary | 9.14% |
| 4 | Financials | 8.63% |
| 5 | Communication Services | 7.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Microsoft
MSFT
$2.95T
| $673M | 4.61% |
2,486,084
+532,491
| +27% | +$135M |
|
2
Apple
AAPL
$4.81T
| $470M | 3.22% |
3,433,627
+220,228
| +7% | +$28.5M |
|
3
Alphabet (Google) Class A
GOOGL
$4.24T
| $443M | 3.03% |
3,626,480
+126,100
| +4% | +$14.7M |
|
4
Merck
MRK
$312B
| $336M | 2.3% |
4,318,307
+486,168
| +13% | +$36.2M |
|
|
5
Regeneron Pharmaceuticals
REGN
$70.5B
| $296M | 2.03% |
530,346
+126,705
| +31% | +$64.2M |
|
|
6
Amgen
AMGN
$198B
| $235M | 1.61% |
963,657
-360,548
| -27% | -$88.7M |
|
7
Danaher
DHR
$127B
| $231M | 1.58% |
971,374
+75,149
| +8% | +$16.7M |
|
8
Thermo Fisher Scientific
TMO
$195B
| $178M | 1.22% |
353,123
-12,703
| -3% | -$5.99M |
|
9
Meta Platforms (Facebook)
META
$1.63T
| $176M | 1.21% |
506,638
+51,619
| +11% | +$16.6M |
|
10
Vertex Pharmaceuticals
VRTX
$122B
| $163M | 1.12% |
807,867
+28,321
| +4% | +$5.92M |
|
11
Amazon
AMZN
$2.66T
| $144M | 0.98% |
835,480
-236,040
| -22% | -$39.2M |
|
|
12
UnitedHealth
UNH
$396B
| $137M | 0.94% |
343,293
+179,390
| +109% | +$71.5M |
|
|
SGEN
13
DELISTED
Seagen Inc. Common Stock
SGEN
| $133M | 0.91% |
841,817
+329,160
| +64% | +$48.9M |
|
|
14
Royal Bank of Canada
RY
$292B
| $132M | 0.9% |
1,303,443
+1,215,246
| +1,378% | +$120M |
|
15
NVIDIA
NVDA
$5.02T
| $127M | 0.87% |
6,347,840
+255,840
| +4% | +$4.1M |
|
16
Adobe
ADBE
$90.3B
| $122M | 0.83% |
208,004
+54,837
| +36% | +$28.3M |
|
17
Procter & Gamble
PG
$345B
| $117M | 0.8% |
868,633
-259,744
| -23% | -$35.1M |
|
|
18
Alphabet (Google) Class C
GOOG
$4.22T
| $116M | 0.8% |
927,500
+193,780
| +26% | +$23.1M |
|
19
Trimble
TRMB
$12.1B
| $113M | 0.77% |
1,379,486
+520,428
| +61% | +$41.4M |
|
20
Visa
V
$677B
| $111M | 0.76% |
476,168
+81,722
| +21% | +$18.7M |
|
21
Gilead Sciences
GILD
$165B
| $110M | 0.75% |
1,592,106
-612,830
| -28% | -$40.9M |
|
22
PayPal
PYPL
$49.3B
| $109M | 0.75% |
374,557
-164,173
| -30% | -$43.4M |
|
23
Alibaba
BABA
$283B
| $108M | 0.74% |
476,093
+46,427
| +11% | +$10.3M |
|
24
Johnson & Johnson
JNJ
$603B
| $106M | 0.73% |
645,194
+41,249
| +7% | +$6.83M |
|
25
Citigroup
C
$223B
| $104M | 0.71% |
1,464,214
+18,146
| +1% | +$1.34M |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q2 2021 Portfolio in Review
As of Q2 2021, Candriam SCA held 958 positions worth $14.6B, up 22% from $12B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Candriam SCA deployed $859M of net new capital in Q2 2021, opening 131 new positions and adding to 364 existing holdings. Its largest new stake was SailPoint Technologies Holdings, Inc. Common Stock: 738,233 shares worth $37.7M.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 34% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $90.3M trimmed.
- Candriam SCA's largest Q2 2021 buy was SailPoint Technologies Holdings, Inc. Common Stock: 738,233 shares worth $37.7M.
- Candriam SCA added most to Microsoft in Q2 2021, an estimated $135M increase.
- Candriam SCA's biggest Q2 2021 reduction was Bristol-Myers Squibb, cutting an estimated $90.3M.
- Candriam SCA fully exited Tenable Holdings in Q2 2021, selling an estimated $31.6M.
- Candriam SCA's ten largest holdings make up 22% of its $14.6B portfolio in Q2 2021.
- Candriam SCA opened 131 new positions and closed 74 in Q2 2021.
- Candriam SCA's portfolio value rose 22% quarter-over-quarter to $14.6B.
Based on Candriam SCA's 13F filing for Q2 2021, filed 20 Jul 2021.